| Number of patients (n) | Percentage (%) | |
Chemotherapy | Docetaxel-Prednisone | 59 | 70.24 |
Weekly used of Taxol | 6 | 7.14 | |
Estramustine acetate | 0 | 0 | |
Abiraterone acetate | 8 | 9.5 | |
Exclusively symptomatic treatment | 11 | 13.09 | |
Enzalutamide | 0 | 0 | |
Sipuleucel -T | 0 | 0 | |
Estrogens | 0 | 0 | |
Continuation of the previous androgen blockage treatment | 73 | 86.90 | |
Adjuvant therapy | Biphosphonate | 59 | 70.23 |
Daunosumab | 0 | 0 | |
RT Palliative | 3 | 3.57 |